Cyclophosphamide Doxorubicin Vincristine Lamivudine
T1401
Phase 2 small_molecule completed
Quick answer
Cyclophosphamide Doxorubicin Vincristine Lamivudine for Non-Hodgkin's Lymphoma is a Phase 2 program (small_molecule) at Taiwan Liposome Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Taiwan Liposome Company
- Indication
- Non-Hodgkin's Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed